Reports Q4 revenue $1.17B, consensus $1.16B. prAna impairment charges negatively impacted diluted earnings per share by 43c. Chairman, President and Chief Executive Officer Tim Boyle commented, "I’m incredibly proud of the financial performance and accomplishments that our global workforce achieved in 2022. I’d like to thank our dedicated employees whose tremendous efforts fueled these results and position us for continued success. For the year, net sales grew 11 percent to a record $3.5 billion, and were up 14 percent on a constant-currency basis. I believe this financial performance could have been even higher, absent supply chain constraints which severely delayed inventory availability throughout the year."
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on COLM: